Beta Blockers vs SSRIs for Anxiety: When to Use Each

Beta blockers and SSRIs are both prescribed for anxiety, but they are not interchangeable. The gap between what each one does is significant enough to change clinical outcomes when the wrong one is chosen.

A beta blocker prescribed to someone with generalized anxiety disorder will reduce their heart rate during anxious moments without reducing the frequency or intensity of the worry, rumination, and anticipatory dread that define GAD. An SSRI prescribed to someone who needs to give a presentation in two hours will do nothing useful: it will not have reached any therapeutic level in the brain and will not reduce the physical symptoms that are about to appear.

The clinical question is not which medication is better for anxiety. It is which type of anxiety each medication actually addresses.

The Core Difference: Physical vs. Psychological Anxiety

The fight-or-flight response has two distinct components. The first is physiological: adrenaline floods the system, heart rate increases, muscles tense, hands sweat, voice trembles. The second is psychological: the cognitive appraisal of threat, the anticipatory dread, the rumination, the avoidance behavior, the generalized sense that something bad is imminent.

Beta blockers address the physiological component. SSRIs address the psychological component. Neither medication addresses the other’s domain particularly well. This determines whether a medication actually helps with the kind of anxiety a patient is experiencing.

How Beta Blockers Work

Beta blockers, primarily propranolol and atenolol in anxiety treatment, work by blocking beta-adrenergic receptors, the receptors that bind adrenaline and norepinephrine to produce the physical anxiety response. When these receptors are blocked, the heart cannot race as fast, the hands do not tremble as much, and sweating is reduced.

The effect is peripheral: beta blockers reduce the body’s physical expression of the stress response. They do not change how the brain perceives or generates anxiety. A person on propranolol may still feel psychologically anxious; they will simply be less visibly and physically affected by it.

Propranolol is a non-selective beta blocker, meaning it blocks both beta-1 (cardiac) and beta-2 (peripheral vascular and bronchial) receptors. The beta-2 blockade is a clinically relevant contraindication: propranolol can cause bronchoconstriction in people with asthma or COPD.

Beta blockers work quickly. Effects typically begin within 30 to 60 minutes of an oral dose and last three to four hours.

When Beta Blockers Are the Right Choice

Beta blockers are clinically appropriate for situational or performance anxiety when:

The anxiety is acute and context-specific, not chronic or generalized. The patient is anxious about a specific upcoming event rather than experiencing persistent anxiety across many contexts and situations.

The primary symptoms are physical. Racing heart, visible tremors, sweating, or voice trembling are the primary problem and the primary reason the anxiety is impairing functioning.

The need is immediate. The patient needs symptom reduction within hours, not weeks.

As-needed dosing is feasible. Beta blockers can be taken only when needed, without building to a therapeutic blood level over weeks.

Clinical guidelines support propranolol taken as needed, one to two hours before a performance situation, at recommended doses of 10-80mg. Taking a test dose on a day without performance obligations is advised to understand how the dose affects heart rate and blood pressure before relying on it in a high-stakes situation.

Performance Anxiety: The Beta Blocker’s Primary Domain

Performance anxiety is the anxiety that arises specifically in performance-related situations: public speaking, musical performance, athletic competition, presentations, academic examinations. For decades, propranolol has been used by musicians, public speakers, surgeons, and test-takers to reduce the physical manifestations of performance anxiety.

A 2022 review published in the International Journal of Molecular Sciences found that propranolol has been used in clinical practice for decades for situational anxiety including stage fright and exam- or interview-related anxiety, and that beta blockade removes physical performance barriers without producing the sedation or cognitive dulling associated with benzodiazepines.

A comprehensive pharmacotherapy review in Frontiers in Psychiatry specifically validates beta blockers for performance-only social anxiety, recommending them as-needed one to two hours before performance at doses of 10-80mg propranolol, while explicitly recommending against standing (daily) beta blockers for generalized social anxiety disorder.

How SSRIs Work for Anxiety

SSRIs work through a completely different mechanism. By blocking the serotonin transporter, they increase serotonin availability in the synaptic space. Over weeks, this produces downstream neuroadaptive changes in the brain circuits that regulate threat appraisal, emotional reactivity, and the chronic worry that characterizes generalized anxiety disorders.

SSRIs do not reduce anxiety acutely. In the first one to two weeks, they may temporarily worsen anxiety through the initial activation syndrome. The full therapeutic effect typically requires four to six weeks of consistent dosing.

What SSRIs address is the underlying anxiety circuitry, not just the acute physical response. For a patient whose anxiety is pervasive, whose worry follows them across contexts, whose avoidance behaviors are limiting their life, SSRIs change the underlying nervous system response.

When SSRIs Are the Right Choice

SSRIs are clinically appropriate when the anxiety is chronic and generalized. The patient experiences anxiety across multiple contexts and situations, not only before specific performance events. The anxiety is impairing daily functioning, relationships, work, or quality of life on an ongoing basis.

SSRIs are the clinical choice when the psychological dimension is as significant as the physical: persistent worry, rumination, anticipatory anxiety, avoidance behavior, and intrusive thoughts are part of the clinical picture, not just a racing heart before a specific event.

SSRIs with FDA approval or strong clinical evidence for anxiety indications include sertraline, paroxetine, and escitalopram for generalized anxiety disorder and social anxiety disorder; sertraline, paroxetine, and fluoxetine for panic disorder and PTSD.

Why Guidelines Don’t Recommend Beta Blockers for Chronic Anxiety

The Anxiety and Depression Association of America’s clinical practice review places SSRIs and SNRIs in the first-line category for anxiety pharmacotherapy and specifically recommends against standing (daily) beta blockers for generalized social anxiety disorder. NICE guidelines for anxiety in the UK do not include beta blockers as recommended treatment and cite insufficient evidence for use in chronic anxiety disorders.

This does not mean beta blockers are harmful for people with chronic anxiety. It means they have not been demonstrated to address the underlying disorder. A patient with GAD who takes propranolol before stressful events will have reduced heart rate during those events. Their background worry, sleep disruption, and daily functional impairment will not be reduced.

A 2024 qualitative study in the British Journal of General Practice found that GPs increasingly prescribe beta blockers for anxiety partly because patients perceive them as less stigmatizing than antidepressants and because they offer immediate relief while patients wait for other treatments. The study identified this as a concern: beta blockers are being used where SSRIs or psychological therapy are the clinically supported options.

Can You Use Both?

Yes, and some patients do appropriately. A patient on a daily SSRI for GAD may also use as-needed propranolol for specific high-stakes performance situations where the physical symptoms would be particularly impairing. This is a clinically reasonable approach for many patients.

A 2024 prospective cohort study published in Cureus found no statistically significant difference in panic disorder symptom severity between SSRI monotherapy and SSRIs combined with beta blockers, suggesting that routine combination therapy is not supported for panic disorder. However, as-needed beta blocker use for specific performance situations alongside chronic SSRI therapy remains a reasonable individual clinical decision.

Contraindications to Consider

Beta blockers have specific contraindications that require prescriber evaluation before use:

Asthma and COPD: Non-selective beta blockers like propranolol cause bronchoconstriction and are contraindicated in patients with obstructive airway disease. Even cardioselective beta blockers are generally used with caution in respiratory disease.

Diabetes: Beta blockers can mask the tachycardia that signals hypoglycemia in insulin-dependent diabetics, requiring more frequent blood sugar monitoring.

Cardiac conditions: Patients with bradycardia, certain arrhythmias, or heart block require careful evaluation before using any beta blocker.

Low resting blood pressure: Beta blockers further reduce blood pressure and heart rate; patients with existing low blood pressure are at higher risk of orthostatic hypotension and dizziness.

These contraindications are why beta blockers for anxiety require a prescriber evaluation, even for as-needed situational use.

How SiggyMD Approaches Anxiety Treatment

For most patients with chronic anxiety disorders, the clinical starting point is an SSRI. The first four to six weeks require patience through the adjustment period, and the check-in data that accumulates over that period is what tells the prescriber whether the medication is producing the right trajectory.

For patients with specific situational performance components to their anxiety, as-needed propranolol may be an appropriate tool alongside or instead of daily SSRI therapy, depending on the clinical picture.

“The beta blocker versus SSRI question comes up frequently because people experiencing anxiety want something that works now,” says Daniel Montville, MD, Psychiatrist at SiggyMD. “Propranolol does work now, for what it does. But what it does is reduce the physical expression of the anxiety response. If the patient’s real problem is that they worry all day, can’t sleep because of anticipatory anxiety, and avoid situations that might trigger anxiety, propranolol before a presentation is not treating their condition. The check-in data helps me understand which picture I’m looking at before recommending one versus the other.”

What Members Are Saying

JN

J.N., 38

Social Anxiety Disorder

“I had been on propranolol for six months and my anxiety was not better. My prescriber reviewed my check-in data and explained that propranolol was helping my heart rate before presentations but doing nothing for the constant background anxiety. We switched the approach. It changed things significantly.”

BW

B.W., 27

Performance Anxiety

“I only have anxiety before presenting at work. My prescriber said an SSRI would be a bigger intervention than I needed. Propranolol as-needed has been the right fit. I take it once a week when I have a meeting. Everything else is normal.”

Member stories reflect real experiences. Names and identifying details have been changed to protect privacy. Results vary. SiggyMD is currently invite-only.

Bottom Line

Beta blockers and SSRIs treat different dimensions of anxiety and are appropriate for different clinical situations. Beta blockers reduce the physical expression of the stress response: the racing heart, the trembling hands, the audible voice shake. SSRIs address the underlying anxiety circuitry that generates chronic worry, avoidance, and generalized impairment.

The clinical decision is not about which medication is stronger. It is about which aspect of anxiety is the actual problem. Situational, performance-based physical anxiety responds to beta blockers. Chronic, generalized, psychologically pervasive anxiety requires the SSRIs that are its first-line treatment.

Sources

• Strawn JR, et al. Pharmacotherapy for Anxiety Disorders: From First-Line Options to Treatment Resistance. Focus. 2021;19(2):215-227.

• Szeleszczuk L, Fraczkowski D. Propranolol versus Other Selected Drugs in the Treatment of Various Types of Anxiety or Stress. International Journal of Molecular Sciences. 2022;23(17):10099.

• Archer C, Kessler D, Wiles N. GPs’ views of prescribing beta-blockers for people with anxiety disorders: a qualitative study. British Journal of General Practice. 2024;74(748):e735-e741.

• Bajabir M, et al. Comparing SSRIs Alone and in Combination With Beta-Blockers for Treating Panic Disorders. Cureus. 2024;16(9):e68862.

• National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder in adults: management. NICE Guideline CG113.

• U.S. National Library of Medicine. Anxiety. MedlinePlus. Accessed May 2026.